Note 8 - Segment Information and Dissaggregated Revenue (Tables)

6 Months Ended

Dec. 31, 2018

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit		Depreciation			Expenditures
Contract Manufacturing	2018	$	10,498	$	1,258	$	11,756	$	1,246	$	66	$	269
	2017		9,159		1,199		10,358		896		55		109
Branded Proprietary Products	2018		48		12		60		21		-		-
	2017		162		10		172		65		1		-
Other Nutraceutical Businesses	2018		181		4		185		63		-		-
	2017		231		39		270		87		1		-
Total Company	2018		10,727		1,274		12,001		1,330		66		269
	2017		9,552		1,248		10,800		1,048		57		109

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit		Depreciation			Expenditures
Contract Manufacturing	2018	$	19,153	$	2,455	$	21,608	$	2,328	$	131	$	$287
	2017		16,981		2,782		19,763		1,731		129		202
Branded Proprietary Products	2018		119		19		138		42		-		-
	2017		181		21		202		97		2		13
Other Nutraceutical Businesses	2018		520		39		559		179		1		-
	2017		502		103		605		225		1		1
Total Company	2018		19,792		2,513		22,305		2,549		132		287
	2017		17,664		2,906		20,570		2,053		132		216

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

	Total Assets as of
	December 31,		June 30,
	2018		2018
Contract Manufacturing	$	20,141	$	12,200
Branded Proprietary Products		545		543
Other Nutraceutical Businesses		1,889		1,825
Total Company	$	22,575	$	14,568